Sarrazin, Christoph <br/><br/>
HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment.  [electronic resource] 

 -  PloS one  2016 
 - e0168544 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0168544  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylates--therapeutic use<br/>Adolescent<br/>Adult<br/>Aged<br/>Aminoisobutyric Acids<br/>Antiviral Agents--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Leucine--analogs & derivatives<br/>Liver Cirrhosis--complications<br/>Male<br/>Middle Aged<br/>Oligopeptides--therapeutic use<br/>Prognosis<br/>Proline--analogs & derivatives<br/>Quinolines<br/>RNA, Viral--genetics<br/>Ribavirin--therapeutic use<br/>Thiazoles--therapeutic use<br/>Viral Load<br/>Young Adult